{"DataElement":{"publicId":"6011792","version":"1","preferredName":"Gastrointestinal Cancer Post Neoadjuvant Treatment Mandard Grade","preferredDefinition":"Number that represents the Mandard tumor regression grade used for upper gastrointestinal carcinomas.","longName":"GI_CA_PNADJ_MND_GRD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6011542","version":"1","preferredName":"Gastrointestinal Malignant Neoplasm Post Neoadjuvant Therapy Mandard Grading System","preferredDefinition":"Pertaining to the stomach and intestines._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Happening at a time subsequent to a reference time; later in time or order._The administration of therapeutic agents prior to the primary treatment for the purpose of making the primary treatment for effective._A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas.","longName":"6011539v1.0:6011540v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6011539","version":"1","preferredName":"Gastrointestinal Malignant Neoplasm","preferredDefinition":"Pertaining to the stomach and intestines.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","longName":"C13359:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C753E1C-510F-2C90-E053-F662850A7629","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6011540","version":"1","preferredName":"Post Neoadjuvant Therapy Mandard Grading System","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:The administration of therapeutic agents prior to the primary treatment for the purpose of making the primary treatment for effective.:A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas.","longName":"C38008:C15665:C140889","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mandard Grading System","conceptCode":"C140889","definition":"A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C753E1C-5121-2C90-E053-F662850A7629","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C753E1C-5132-2C90-E053-F662850A7629","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeDescription":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6011766","version":"1","preferredName":"Mandard Grading System Grade","preferredDefinition":"A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas._A position on a scale of intensity or amount or quality.","longName":"MANDARD_GRD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TRG 1","valueDescription":"Tumor Regression Grade 1","ValueMeaning":{"publicId":"6011771","version":"1","preferredName":"Tumor Regression Grade 1","longName":"6011771","preferredDefinition":"Complete regression; fibrosis without detectable tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Grade 1","conceptCode":"C140890","definition":"Complete regression; fibrosis without detectable tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DFFA-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C79789D-C507-0243-E053-F662850A10B5","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","deletedIndicator":"No"},{"value":"TRG 2","valueDescription":"Tumor Regression Grade 2","ValueMeaning":{"publicId":"6011770","version":"1","preferredName":"Tumor Regression Grade 2","longName":"6011770","preferredDefinition":"Presence of fibrosis with scattered tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Grade 2","conceptCode":"C140891","definition":"Presence of fibrosis with scattered tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DFD3-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C79789D-C51B-0243-E053-F662850A10B5","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","deletedIndicator":"No"},{"value":"TRG 3","valueDescription":"Tumor Regression Grade 3","ValueMeaning":{"publicId":"6011769","version":"1","preferredName":"Tumor Regression Grade 3","longName":"6011769","preferredDefinition":"Presence of fibrosis and tumor cells with a preponderance of fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Grade 3","conceptCode":"C140892","definition":"Presence of fibrosis and tumor cells with a preponderance of fibrosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DFAC-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C79789D-C52F-0243-E053-F662850A10B5","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","deletedIndicator":"No"},{"value":"TRG 4","valueDescription":"Tumor Regression Grade 4","ValueMeaning":{"publicId":"6011768","version":"1","preferredName":"Tumor Regression Grade 4","longName":"6011768","preferredDefinition":"Presence of fibrosis and tumor cells with preponderance of tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Grade 4","conceptCode":"C140893","definition":"Presence of fibrosis and tumor cells with preponderance of tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DF85-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C79789D-C543-0243-E053-F662850A10B5","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","deletedIndicator":"No"},{"value":"TRG 5","valueDescription":"Tumor Regression Grade 5","ValueMeaning":{"publicId":"6011767","version":"1","preferredName":"Tumor Regression Grade 5","longName":"6011767","preferredDefinition":"Presence of tumor without changes of regression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Grade 5","conceptCode":"C140894","definition":"Presence of tumor without changes of regression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DF5E-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C79789D-C557-0243-E053-F662850A10B5","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6011765","version":"1","preferredName":"Mandard Grading System Grade","preferredDefinition":"A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas.:A position on a scale of intensity or amount or quality.","longName":"C140889:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mandard Grading System","conceptCode":"C140889","definition":"A tumor regression grading (TRG) system commonly used for upper gastrointestinal carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DF34-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"ONEDATA","dateModified":"2017-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DF45-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeDescription":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mandard grade","type":"Preferred Question Text","description":"Mandard grade","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C725AB5-C369-1B07-E053-F662850A8C3E","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeDescription":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}